Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula
Hui Li
Journal of Ethnopharmacology (2019) Vol. 251, pp. 112442-112442
Closed Access | Times Cited: 126

Showing 26-50 of 126 citing articles:

Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
Wenqing Li, Wenhao Liu, Die Qian, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
Yang Nan, HongChan Su, Xiao-Mei Lian, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 19
Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis
H. J. Yang, Ying Zou, Jun Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis
An Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24437-e24437
Open Access | Times Cited: 4
Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-κB signaling pathway to relieve liver fibrosis
Sujuan Ren, Rui Zhou, Zhishu Tang, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111598-111598
Closed Access | Times Cited: 4
RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway
Hanlin Shi, Xiaohong Duan, Jingcheng Dong, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117963-117963
Closed Access | Times Cited: 4
Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice
Jian Shi, Lin Zhu, Bangyi Tang, et al.
Journal of Natural Medicines (2024) Vol. 78, Iss. 3, pp. 633-643
Closed Access | Times Cited: 4
Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?
Yue Chang, Li Hai
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 2, pp. 222-229
Open Access | Times Cited: 31
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Dong Ji, Yan Chen, Qinghua Shang, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 8, pp. 1676-1685
Open Access | Times Cited: 26
Systematic analysis of the mechanism of Xiaochaihu decoction in hepatitis B treatment via network pharmacology and molecular docking
Ya Zeng, Shen Xiao, Luna Yang, et al.
Computers in Biology and Medicine (2021) Vol. 138, pp. 104894-104894
Closed Access | Times Cited: 25
An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms
Qianqian Zhao, Jinwei Bai, Yiwei Chen, et al.
Journal of Ethnopharmacology (2022) Vol. 297, pp. 115567-115567
Closed Access | Times Cited: 18
Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway
Manman Guo, Zhongda Wang, Jinya Dai, et al.
Phytomedicine (2022) Vol. 112, pp. 154587-154587
Closed Access | Times Cited: 18
Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review
Liyue Zhou, Yifan Li, Qiangwei Liang, et al.
Journal of drug targeting (2022) Vol. 30, Iss. 6, pp. 577-588
Closed Access | Times Cited: 16
Study on mechanism of action of total flavonoids from Cortex Juglandis Mandshuricae against alcoholic liver disease based on “gut-liver axis”
Huiru Liu, Wenwen Meng, Dongsheng Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 10
Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Yanwei Li, Yunrui LU, Mozuo NIAN, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 9, pp. 643-657
Closed Access | Times Cited: 10
The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives
Rakesh Sahu, Sourav Goswami, G. Narahari Sastry, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 9
Sophoricoside attenuates autoimmune‑mediated liver injury through the regulation of oxidative stress and the NF‑κB signaling pathway
Yu Chen, Lei Yu, Han Wang, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 3
Open Access | Times Cited: 9
Tanshinone IIA regulates CCl4 induced liver fibrosis in C57BL/6J mice via the PI3K/Akt and Nrf2/HO‐1 signaling pathways
Q. Li, Dong-Rui Huang, Wenjing Liao, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 3
Discovery and validation of COX2 as a target of flavonoids in Apocyni Veneti Folium: Implications for the treatment of liver injury
Cuihua Chen, Feiyan Chen, Ling Gu, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117919-117919
Closed Access | Times Cited: 3
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine
Shihao Zheng, Chengyuan Xue, Size Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?—a narrative review
Yu-tong Liu, Shuang-Lin Qi, Kewei Sun
Annals of Palliative Medicine (2021) Vol. 10, Iss. 4, pp. 4846-4857
Open Access | Times Cited: 20
Small molecules of herbal origin for osteoarthritis treatment: in vitro and in vivo evidence
Penghui Zhang, Kaihu Li, Amir Kamali, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation
Shou-Jia Wang, Wen Ye, Wanyi Li, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 116053-116053
Closed Access | Times Cited: 15
On the Core Prescriptions and Their Mechanisms of Traditional Chinese Medicine in Hepatitis B, Liver Cirrhosis, and Liver Cancer Treatment
Zhendong Wang, Yong Zhang, Qiuyun Zhang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 14
Prospective therapeutics for intestinal and hepatic fibrosis
Xin Li, Mengli Yu, Qingwei Zhao, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 8

Scroll to top